Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1995 1
1996 1
1998 2
1999 1
2000 3
2001 1
2004 1
2008 2
2009 2
2010 1
2011 2
2012 1
2014 4
2015 2
2016 1
2017 2
2018 2
2020 4
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial.
Cruz LR, Baladrón I, Rittoles A, Díaz PA, Valenzuela C, Santana R, Vázquez MM, García A, Chacón D, Thompson D, Perera G, González A, Reyes R, Torres L, Pérez J, Valido Y, Rodriguez R, Vázquez-Bloomquist DM, Rosales M, Ramón AC, Pérez GV, Guillén G, Muzio V, Perera Y, Perea SE; ATENEA-Co-300 Group. Cruz LR, et al. Among authors: perea se. ACS Pharmacol Transl Sci. 2020 Dec 11;4(1):206-212. doi: 10.1021/acsptsci.0c00175. eCollection 2021 Feb 12. ACS Pharmacol Transl Sci. 2020. PMID: 33615173 Free PMC article.
CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo.
Farina HG, Benavent Acero F, Perera Y, Rodríguez A, Perea SE, Castro BA, Gomez R, Alonso DF, Gomez DE. Farina HG, et al. Among authors: perea se. Exp Cell Res. 2011 Jul 15;317(12):1677-88. doi: 10.1016/j.yexcr.2011.04.011. Epub 2011 May 1. Exp Cell Res. 2011. PMID: 21565189
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page